Telo Genomics Corp.
TELO.V
TSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.95% | -31.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.80% | -18.56% | |||
| Operating Income | 3.80% | 18.56% | |||
| Income Before Tax | 3.97% | 23.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.97% | 23.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.97% | 23.00% | |||
| EBIT | 3.80% | 18.56% | |||
| EBITDA | 6.94% | 18.63% | |||
| EPS Basic | 2.56% | 23.53% | |||
| Normalized Basic EPS | 0.00% | 22.58% | |||
| EPS Diluted | 1.37% | -43.14% | |||
| Normalized Diluted EPS | 0.00% | 22.58% | |||
| Average Basic Shares Outstanding | 0.04% | 0.41% | |||
| Average Diluted Shares Outstanding | 0.04% | 0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||